Osteochondral Lesion of the Talus 2026 | DPM

OLT Grade (MRI / Arthroscopic)	Cartilage Status	Bone Status	Stability	Treatment
Grade I	Intact cartilage; signal change only	Bone marrow edema; no subchondral fracture	Stable	Conservative: offloading + physical therapy; often resolves in 3–4 months
Grade II	Cartilage attached but partially separated	Subchondral fracture; edema	Stable	Conservative first (6 months); arthroscopy if failed — microfracture or fixation
Grade IIa	Cartilage with fluid-filled subchondral cyst	Cyst formation; bone loss	Stable to unstable	Lower threshold for surgery; cyst debridement + bone grafting + microfracture
Grade III	Cartilage fragment completely detached but in situ	Subchondral bone exposed or undermined	Unstable (in place)	Arthroscopic excision + microfracture; or fixation if fragment viable
Grade IV	Loose body — fragment completely displaced into joint	Bare subchondral bone at defect	Unstable (displaced)	Arthroscopic loose body removal + microfracture; OCA for large defects (>1.5 cm²)

Surgical Procedure	Best For	Mechanism	Recovery	Long-Term Outcome
Arthroscopic debridement + microfracture	Defects <1.5 cm²; primary OLT; Grade III–IV	Perforates subchondral bone → fibrocartilage fills defect (not hyaline, but functional)	NWB 6–8 weeks; full activity 4–6 months	80–85% good-to-excellent outcomes; fibrocartilage may degrade over 5–10 years
Osteochondral autograft transfer (OATS)	Defects 1–2 cm²; failed microfracture; young active patients	Harvest cartilage plug from non-weight-bearing area of knee; transplant to talus	NWB 6–8 weeks; full activity 6–9 months	85–90% good outcomes; hyaline cartilage preserved; donor site morbidity small risk
Osteochondral allograft (OCA)	Large defects >2 cm²; failed OATS; significant bone loss	Cadaveric matched osteochondral plug; replaces defect exactly	NWB 8–10 weeks; full activity 9–12 months	70–80% good outcomes; no donor morbidity; allograft incorporation variable
Autologous chondrocyte implantation (ACI/MACI)	Large defects; failed microfracture; young patients	Harvest chondrocytes; grow in lab 4 weeks; re-implant into defect	NWB 6–8 weeks; full activity 12–18 months	Growing evidence; 75–85% good outcomes; staged procedure (2 surgeries)
Conservative (boot + PT)	Grade I–II; first-line all grades; pediatric patients	Offloading allows bone edema to resolve; cartilage to stabilize	4–6 weeks boot; PT 3–6 months	Grade I: ~90% resolve; Grade II: ~50–60% resolve without surgery

You sprained your ankle six months ago. The acute swelling resolved, but a dull ache persists deep inside the joint. Sometimes it clicks. Occasionally it gives way. You were told the sprain should have healed by now — and you’re wondering why it hasn’t. This scenario is the most common presentation of an osteochondral lesion of the talus (OLT), and it accounts for a significant proportion of the “chronic ankle sprains” we evaluate at Balance Foot & Ankle. The key to recognizing OLTs is understanding that a standard ankle X-ray — even a good one — misses the majority of these lesions. Until an MRI is obtained, the diagnosis remains hidden, and treatment remains ineffective because it is treating the wrong thing.

What Is an Osteochondral Lesion of the Talus

The talus is the dome-shaped bone that forms the lower half of the ankle joint — your tibia (shin bone) rides directly on top of it. The surface of the talar dome is covered by articular cartilage: smooth, shock-absorbing, hyaline cartilage that allows frictionless ankle motion. An osteochondral lesion (OLT) is a focal injury to this cartilage and the subchondral bone beneath it. The injury can range from a softening of the cartilage surface (Grade I) to a completely detached bone-cartilage fragment floating within the joint (Grade IV).

What makes OLTs clinically significant beyond their immediate symptoms is their long-term trajectory. Articular cartilage has minimal intrinsic healing capacity — it lacks blood vessels and has very limited cell turnover. An unstable OLT that is not treated does not simply stay the same; it progressively damages the opposing tibial cartilage surface, and the result over years is post-traumatic ankle arthritis. In our clinic, we treat OLTs with urgency — not because acute surgical intervention is always required, but because delaying diagnosis and management accelerates the path to arthritis.

Symptoms of Osteochondral Lesion of the Talus

The symptom picture of an OLT is remarkably consistent once you recognize the pattern, though its subtlety is exactly what causes it to be missed for months or years after the initial injury.

• Deep ankle joint pain — not lateral ligament pain, but pain that feels “inside” the joint, often difficult to localize precisely
• Persistent swelling — the ankle never fully returns to normal size after the inciting sprain; a chronic mild effusion is present
• Clicking, catching, or locking — a loose or unstable cartilage fragment creates mechanical symptoms with ankle motion
• Giving way — not from ligament instability, but from the OLT fragment interfering with smooth joint motion at a critical moment
• Stiffness after inactivity — the ankle is stiff and achy after sitting or sleeping, easing with movement but returning with prolonged activity
• Pain with weight-bearing on uneven surfaces — multi-directional ankle loading (stairs, hills, trails) is particularly provocative
• No significant improvement after standard ankle sprain treatment — the defining feature; if the “sprain” hasn’t substantially improved by 6–8 weeks, an OLT must be ruled out

Causes and Mechanisms of OLT

OLTs are caused by acute traumatic events (most commonly) or by repetitive microtrauma over time. Understanding the mechanism helps predict lesion location — which in turn guides surgical approach when intervention is required.

Traumatic OLTs (80–95% of cases): The most common mechanism is an inversion ankle sprain — the foot rolls inward, and the lateral talar dome impacts the fibula or sustentaculum tali with a shear-compression force that damages the cartilage and subchondral bone. Lateral OLTs (on the outer talar dome) are more common after inversion injuries and tend to be larger and more superficial. Medial OLTs (inner talar dome) typically result from dorsiflexion-inversion injuries, are often deeper, and are more likely to be cystic (with bone cavity formation). A significant proportion of ankle sprains — some studies estimate 6.5% — develop OLTs that are missed initially.

Atraumatic and chronic OLTs: A minority of OLTs develop without a clear acute injury, particularly in the medial talar dome. These are thought to result from repetitive microtrauma, ischemia, or osteonecrosis. Patients typically present with gradual-onset ankle pain without a memorable injury. Basketball players, dancers, and distance runners are at elevated risk for this pattern.

How OLT Is Diagnosed

Diagnosing an OLT requires appropriate imaging — clinical examination alone is insufficient, and plain X-rays alone are inadequate. The sequence of imaging we use at Balance Foot & Ankle follows a specific logic based on what each modality can and cannot detect.

Plain X-ray: First-line imaging, but extremely limited for OLTs. Radiographs detect bony changes in Grade III–IV lesions — subchondral cysts, loose bony fragments, or sclerosis. Grade I and II lesions are cartilage-only injuries invisible on X-ray. Studies show X-ray misses 50–70% of OLTs. A normal ankle X-ray after a sprain with persistent symptoms does not exclude an OLT — it simply means the lesion hasn’t reached bony involvement yet, or the bony changes are subtle.

MRI — the gold standard: MRI visualizes articular cartilage directly and detects bone marrow edema, subchondral cysts, and fluid at the lesion interface. It is the single most important diagnostic step for suspected OLT. MRI both confirms the diagnosis and grades the lesion, which guides treatment selection. A dedicated ankle MRI protocol is required — a general extremity MRI with lower resolution may miss small lesions.

CT scan: Excellent for visualizing bone architecture, cyst size, and lesion containment. Used as a complement to MRI when surgical planning is being made — CT defines the bony morphology precisely, while MRI assesses cartilage viability and fragment stability. We obtain both MRI and CT for surgical planning in most symptomatic OLTs requiring intervention.

Diagnostic arthroscopy: The historical gold standard before MRI quality improved. Now reserved for cases where imaging is equivocal but clinical suspicion remains high. Arthroscopy allows direct visualization and tactile assessment of cartilage stability — a probe can determine whether the lesion is stable (adherent, non-mobile) or unstable (partially attached, mobile, or detached).

OLT Classification and Grading

The Berndt and Harty classification and the MRI-based Hepple classification are the two systems most commonly used for OLTs. Both predict treatment requirements and outcomes.

Differential Diagnosis for OLT

Conservative Treatment for OLT

Conservative management is appropriate for Grade I and Grade II OLTs in patients who are not yet candidates for surgery or who have not completed adequate conservative care. The evidence supports a success rate of approximately 45–54% for conservative management of symptomatic OLTs — meaning roughly half of patients with Grade I–II lesions will respond sufficiently to avoid surgery. The selection of patients for conservative versus surgical care is based on lesion grade, size, location, duration of symptoms, and patient activity demands.

Non-weight-bearing immobilization — 6 to 12 weeks: The cornerstone of conservative OLT management. A non-weight-bearing cast or CAM boot removes mechanical loading from the talar dome, allowing the subchondral bone edema to resolve and, in Grade I lesions, the subchondral trabeculae to remodel without continued compressive damage. This is not optional or partial — true non-weight-bearing is required. Studies show that partial compliance with NWB dramatically reduces conservative success rates.

Physical therapy — after NWB phase: Once weight-bearing resumes, proprioceptive rehabilitation is critical. Ankle sprains that precede OLTs cause significant proprioceptive loss, contributing to recurrent instability that re-loads the lesion. Balance training, peroneal strengthening, and ankle stability exercises restore neuromuscular control. Pool walking and cycling during the NWB phase maintain cardiovascular fitness without talar dome loading.

Intra-articular injection: Corticosteroid injection into the ankle joint can reduce synovitis and pain, providing a therapeutic window for rehabilitation. Platelet-rich plasma (PRP) injections have emerging evidence for cartilage healing support in Grade I–II OLTs, though the evidence base is still developing. Neither injection is a definitive treatment — they are adjuncts to the rehabilitation program.

Surgical Treatment for OLT

Surgical intervention is indicated for Grade III–IV lesions, Grade II lesions that fail 3–6 months of conservative care, lesions larger than 15mm in any dimension, cystic lesions, and patients with high functional demands who cannot tolerate prolonged conservative management. Ankle arthroscopy is the primary surgical platform — minimally invasive, with two or three small portals and camera-guided instrumentation. Open surgery is reserved for medial lesions requiring a medial malleolus osteotomy for access and for salvage procedures.

Debridement and microfracture (most common for primary lesions): The unstable cartilage and necrotic subchondral bone are removed arthroscopically. Then the exposed bone bed is perforated with a microfracture awl in a 3–4mm grid pattern. These perforations release mesenchymal stem cells from bone marrow into the defect, which form a blood clot and ultimately differentiate into fibrocartilage — not perfect hyaline cartilage, but functional repair tissue. Best results occur in lesions smaller than 15mm and in younger patients. Success rates of 75–85% are reported for primary microfracture in appropriately selected patients.

Osteochondral autograft transfer (OATS): For larger lesions (>15mm) or failed microfracture, a cylindrical plug of hyaline cartilage and bone is harvested from a non-weight-bearing area of the knee (or ipsilateral ankle) and press-fit into the prepared OLT defect. OATS provides true hyaline cartilage repair — theoretically more durable than fibrocartilage. Donor site morbidity is a consideration; most patients experience some temporary knee discomfort post-procedure.

Retrograde drilling: Used for intact cartilage lesions (Grade II) with subchondral cysts. A drill is passed from outside the ankle through the talus to the cyst under fluoroscopic guidance, without disturbing the cartilage surface. Drilling stimulates bone healing within the cyst. This allows cyst resolution while preserving the cartilage layer.

Recovery from OLT Surgery

Recovery from arthroscopic OLT surgery follows a staged protocol designed to allow the repair tissue to mature without premature mechanical loading. The most common error is progressing weight-bearing too early — fibrocartilage repair tissue requires 6–8 weeks of NWB to develop adequate structural integrity before it can safely accept load.

0–6 weeks: Non-weight-bearing in a cast or boot. Pool therapy and stationary cycling begin at 2 weeks for cardiovascular conditioning. Ankle range-of-motion exercises in a non-weight-bearing position maintain joint mobility.

6–12 weeks: Progressive weight-bearing in a CAM boot, transitioning to regular shoes with orthotic insoles by 8–10 weeks. Physical therapy intensifies with balance training, proprioception, and progressive strength work.

3–6 months: Low-impact sport return (cycling, swimming, elliptical). Jogging introduced at 4–5 months with CURREX RunPro insoles in a stability shoe. Return to cutting sports and pivoting activities at 5–6 months if functional testing is passed.

Long-term: Regular follow-up MRI at 6–12 months assesses repair tissue maturation. PowerStep Pinnacle insoles worn daily during the return-to-activity phase distribute ankle joint load more evenly, protecting the healing repair tissue. Doctor Hoy’s Natural Pain Relief Gel provides topical anti-inflammatory support for activity-related ankle soreness throughout the rehabilitation period without systemic side effects.

Recommended Products During OLT Recovery

Sources

1. Hepple S, Winson IG, Glew D. Osteochondral lesions of the talus: a revised classification. Foot Ankle Int. 1999;20(12):789-93.
2. Berndt AL, Harty M. Transchondral fractures (osteochondritis dissecans) of the talus. J Bone Joint Surg Am. 1959;41-A(6):988-1020.
3. Zengerink M, Struijs PA, Tol JL, van Dijk CN. Treatment of osteochondral lesions of the talus: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2010;18(2):238-46.
4. Verhagen RA, Struijs PA, Bossuyt PM, van Dijk CN. Systematic review of treatment strategies for osteochondral defects of the talar dome. Foot Ankle Clin. 2003;8(2):233-42.
5. Ferkel RD, Zanotti RM, Komenda GA, et al. Arthroscopic treatment of chronic osteochondral lesions of the talus: long-term results. Am J Sports Med. 2008;36(9):1750-62.